Martine M. Mirrione
Brookhaven National Laboratory
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Martine M. Mirrione.
Nature | 2011
Bo Li; Joaquin Piriz; Martine M. Mirrione; ChiHye Chung; Christophe D. Proulx; Daniela Schulz; Fritz A. Henn; Roberto Malinow
The cellular basis of depressive disorders is poorly understood. Recent studies in monkeys indicate that neurons in the lateral habenula (LHb), a nucleus that mediates communication between forebrain and midbrain structures, can increase their activity when an animal fails to receive an expected positive reward or receives a stimulus that predicts aversive conditions (that is, disappointment or anticipation of a negative outcome). LHb neurons project to, and modulate, dopamine-rich regions, such as the ventral tegmental area (VTA), that control reward-seeking behaviour and participate in depressive disorders. Here we show that in two learned helplessness models of depression, excitatory synapses onto LHb neurons projecting to the VTA are potentiated. Synaptic potentiation correlates with an animal’s helplessness behaviour and is due to an enhanced presynaptic release probability. Depleting transmitter release by repeated electrical stimulation of LHb afferents, using a protocol that can be effective for patients who are depressed, markedly suppresses synaptic drive onto VTA-projecting LHb neurons in brain slices and can significantly reduce learned helplessness behaviour in rats. Our results indicate that increased presynaptic action onto LHb neurons contributes to the rodent learned helplessness model of depression.
Journal of Neuroscience Methods | 2006
Wynne K. Schiffer; Martine M. Mirrione; Anat Biegon; David Alexoff; Vinal Patel; Stephen L. Dewey
Despite the widespread use of chronic brain implants in experimental and clinical settings, the effects of these long-term procedures on brain metabolism and receptor expression remain largely unknown. Under the hypothesis that intracerebral microdialysis transiently alters tissue metabolism, we performed a series of 18FDG microPET scans prior to and following surgical implantation of microdialysis cannulae. Parallel microPET measures using the competitive dopamine (DA) D2 receptor antagonist, 11C-raclopride, provided an assay of DA stability in these same animals. 18FDG scans were performed prior to microdialysis cannulation and again at 2, 12, 24, 48, 120, 168, 360 and 500 h (0.2, 0.5, 1, 2, 5, 7, 15 and 25 days). Separate animals received a sham surgery and the control group had no surgical intervention. For the first 24 h (scans at 2, 12 and 24 h post-surgery) uptake was reduced in both hemispheres. However, by 48 h, contralateral uptake had returned to pre-surgical levels. The striking finding was that from 48 to 500 h, the microdialysis cannulation produced widespread ipsilateral reductions in 18FDG uptake that encompassed the entire hemisphere. Despite the extent and persistence of these reductions, 11C-raclopride binding and ECF DA concentrations remained stable.
NeuroImage | 2007
Martine M. Mirrione; Wynne K. Schiffer; Joanna S. Fowler; David Alexoff; Stephen L. Dewey; Stella E. Tsirka
Medically refractory seizures cause inflammation and neurodegeneration. Seizure initiation thresholds have been linked in mice to the serine protease tissue plasminogen activator (tPA); mice lacking tPA exhibit resistance to seizure induction, and the ensuing inflammation and neurodegeneration are similarly suppressed. Seizure foci in humans can be examined using PET employing 2-deoxy-2[(18)F]fluoro-d-glucose ((18)FDG) as a tracer to visualize metabolic dysfunction. However, there currently exist no such methods in mice to correlate measures of brain activation with behavior. Using a novel method for small animal PET data analysis, we examine patterns of (18)FDG uptake in wild-type and tPA(-/-) mice and find that they correlate with the severity of drug-induced seizure initiation. Furthermore, we report unexpected activations that may underlie the tPA modulation of seizure susceptibility. The methods described here should be applicable to other mouse models of human neurological disease.
Neurobiology of Disease | 2010
Martine M. Mirrione; Dorothy K. Konomos; Iordanis Gravanis; Stephen L. Dewey; Adriano Aguzzi; Frank L. Heppner; Stella E. Tsirka
Activated microglia have been associated with neurodegeneration in patients and in animal models of Temporal Lobe Epilepsy (TLE), however their precise functions as neurotoxic or neuroprotective is a topic of significant investigation. To explore this, we examined the effects of pilocarpine-induced seizures in transgenic mice where microglia/macrophages were conditionally ablated. We found that unilateral ablation of microglia from the dorsal hippocampus did not alter acute seizure sensitivity. However, when this procedure was coupled with lipopolysaccharide (LPS) preconditioning (1 mg/kg given 24 h prior to acute seizure), we observed a significant pro-convulsant phenomenon. This effect was associated with lower metabolic activation in the ipsilateral hippocampus during acute seizures, and could be attributed to activity in the mossy fiber pathway. These findings reveal that preconditioning with LPS 24 h prior to seizure induction may have a protective effect which is abolished by unilateral hippocampal microglia/macrophage ablation.
Frontiers in Human Neuroscience | 2014
Martine M. Mirrione; Daniela Schulz; Kyle A.B. Lapidus; Samuel Zhang; Wayne K. Goodman; Fritz A. Henn
Uncontrollable stress can have a profound effect on an organisms ability to respond effectively to future stressful situations. Behavior subsequent to uncontrollable stress can vary greatly between individuals, falling on a spectrum between healthy resilience and maladaptive learned helplessness. It is unclear whether dysfunctional brain activity during uncontrollable stress is associated with vulnerability to learned helplessness; therefore, we measured metabolic activity during uncontrollable stress that correlated with ensuing inability to escape future stressors. We took advantage of small animal positron emission tomography (PET) and 2-deoxy-2[18F]fluoro-D-glucose (18FDG) to probe in vivo metabolic activity in wild type Sprague Dawley rats during uncontrollable, inescapable, unpredictable foot-shock stress, and subsequently tested the animals response to controllable, escapable, predictable foot-shock stress. When we correlated metabolic activity during the uncontrollable stress with consequent behavioral outcomes, we found that the degree to which animals failed to escape the foot-shock correlated with increased metabolic activity in the lateral septum and habenula. When used a seed region, metabolic activity in the habenula correlated with activity in the lateral septum, hypothalamus, medial thalamus, mammillary nuclei, ventral tegmental area, central gray, interpeduncular nuclei, periaqueductal gray, dorsal raphe, and rostromedial tegmental nucleus, caudal linear raphe, and subiculum transition area. Furthermore, the lateral septum correlated with metabolic activity in the preoptic area, medial thalamus, habenula, interpeduncular nuclei, periaqueductal gray, dorsal raphe, and caudal linear raphe. Together, our data suggest a group of brain regions involved in sensitivity to uncontrollable stress involving the lateral septum and habenula.
The Journal of Neuroscience | 2010
Jaime Emmetsberger; Martine M. Mirrione; Chun Zhou; Mónica Fernández-Monreal; Mustafa Siddiq; Kyungmin Ji; Stella E. Tsirka
Glutamatergic neurons contain free zinc packaged into neurotransmitter-loaded synaptic vesicles. Upon neuronal activation, the vesicular contents are released into the synaptic space, whereby the zinc modulates activity of postsynaptic neurons though interactions with receptors, transporters and exchangers. However, high extracellular concentrations of zinc trigger seizures and are neurotoxic if substantial amounts of zinc reenter the cells via ion channels and accumulate in the cytoplasm. Tissue plasminogen activator (tPA), a secreted serine protease, is also proepileptic and excitotoxic. However, tPA counters zinc toxicity by promoting zinc import back into the neurons in a sequestered form that is nontoxic. Here, we identify the zinc influx transporter, ZIP4, as the pathway through which tPA mediates the zinc uptake. We show that ZIP4 is upregulated after excitotoxin stimulation of the mouse, male and female, hippocampus. ZIP4 physically interacts with tPA, correlating with an increased intracellular zinc influx and lysosomal sequestration. Changes in prosurvival signals support the idea that this sequestration results in neuroprotection. These experiments identify a mechanism via which neurons use tPA to efficiently neutralize the toxic effects of excessive concentrations of free zinc.
Frontiers in Neural Circuits | 2016
Yongsoo Kim; Zinaida Perova; Martine M. Mirrione; Kith Pradhan; Fritz A. Henn; Stephen D. Shea; Pavel Osten; Bo Li
Some individuals are resilient, whereas others succumb to despair in repeated stressful situations. The neurobiological mechanisms underlying such divergent behavioral responses remain unclear. Here, we employed an automated method for mapping neuronal activity in search of signatures of stress responses in the entire mouse brain. We used serial two-photon tomography to detect expression of c-FosGFP – a marker of neuronal activation – in c-fosGFP transgenic mice subjected to the learned helplessness (LH) procedure, a widely used model of stress-induced depression-like phenotype in laboratory animals. We found that mice showing “helpless” behavior had an overall brain-wide reduction in the level of neuronal activation compared with mice showing “resilient” behavior, with the exception of a few brain areas, including the locus coeruleus, that were more activated in the helpless mice. In addition, the helpless mice showed a strong trend of having higher similarity in whole-brain activity profile among individuals, suggesting that helplessness is represented by a more stereotypic brain-wide activation pattern. This latter effect was confirmed in rats subjected to the LH procedure, using 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography to assess neural activity. Our findings reveal distinct brain activity markings that correlate with adaptive and maladaptive behavioral responses to stress, and provide a framework for further studies investigating the contribution of specific brain regions to maladaptive stress responses.
Epilepsy Research and Treatment | 2011
Martine M. Mirrione; Stella E. Tsirka
Small animal neuroimaging has become increasingly available to researchers, expanding the breadth of questions studied with these methods. Applying these noninvasive techniques to the open questions underlying epileptogenesis is no exception. A major advantage of small animal neuroimaging is its translational appeal. Studies can be well controlled and manipulated, examining the living brain in the animal before, during, and after the disease onset or disease treatment. The results can also be compared to data collected on human patients. Over the past decade, we and others have explored metabolic patterns in animal models of epilepsy to gain insight into the circuitry underlying development of the disease. In this paper, we provide technical details on how metabolic imaging that uses 2-deoxy-2[18F]fluoro-D-glucose (18FDG) and positron emission tomography (PET) is performed and explain the strengths and limitations of these studies. We will also highlight recent advances toward understanding epileptogenesis through small animal imaging.
Archive | 2011
Martine M. Mirrione; Stella E. Tsirka
Microglia are the immune competent cells of the CNS and comprise the major mechanism of self-defense against brain injury, infections and disease. Activation of microglia occur as a response to these insults, and both neurotoxic and neuroprotective factors can be released (Streit et al., 1999, Streit, 2002, Schwartz, 2003, Schwartz et al., 2006). There is a great deal of evidence suggesting that microglia have a role in neurodegenerative diseases, either to promote the pathology, or to counter it. However in the case of epilepsy, specific questions still remain including how, why, and when microglia are activated. In this first section, we will provide a general introduction to the role of activated microglia in the central nervous system (CNS). In subsequent sections, we will specifically discuss evidence of a functional role for microglia in epilepsy. In the normal brain, the majority of microglia are in the resting, or quiescent ramified state. This shape with their long processes, allows them to quickly assess and respond to CNS injury or pathogens. During excitotoxic insult or inflammation, microglia become activated. This activation is manifested morphologically by retraction of their processes and changing to a rounded amoeboid morphology. Microglia also become proliferative and migratory. Their electrophysiological characteristics are altered and the expression of potassium, proton, sodium, calcium and chloride currents changes (Eder, 1998, Ducharme et al., 2007, Averaimo et al., 2010, Skaper, 2011). Once activated, the primary function of microglia is to return injured tissue to homeostasis (Streit and Xue, 2009), but this is a double edged sword, as their presence can be both ‘good’ and ‘bad’ for neurons. These effects are complex and overlapping, and not necessarily mutually exclusive. In an effort to protect surviving cells during pathological conditions, microglia have been shown to ‘execute’ damaged or dying neurons injured from excitotoxicity in order to protect nearby cells from lytic release of toxic intracellular contents. Thus, microglia will facilitate local tissue repair by phagocytosing these cells and cell debris. This occurs through initial mobilization of cells near the site of injury and recruitment of distant microglia into the damaged area, which release proinflammatory mediators. At appropriately minimal and transient microglial activation, this process is ultimately neuroprotective (Vilhardt, 2005). However unregulated hyperactivation and release of toxic factors, such as nitric oxide (NO),
The Journal of Nuclear Medicine | 2007
Wynne K. Schiffer; Martine M. Mirrione; Stephen L. Dewey